The Swiss voice in the world since 1935
Top stories
Stay in touch with Switzerland

Swiss health office and pharma firm at odds over flu spray

flu patient in bed drinking tea
A few days in bed might also help to recover from flu. Keystone / Martin Ruetschi

The Swiss health authorities and the manufacturer AstraZeneca are at loggerheads over a nasal spray to vaccinate children and adolescents against influenza.

The British-Swedish manufacturer told the Swiss Keystone-SDA agency that it had been asked by the Federal Office of Public Health to introduce its product in Switzerland two years ago.

However, the health office had later set unacceptable financial conditions, a company spokesman said.

For its part, the health office told Keystone-SDA that AstraZeneca is asking for remuneration at more than twice the price of comparable products.

Therefore no agreement has been reached so far to distribute the vaccine and the marketing authorisation holder has withdrawn its application, the office added.

As a result, some 10,000 does of the spray is still in cold storage, while an application to drugs regulator, Swissmedic, for the free distribution of the doses via paediatric hospitals or doctors’ surgeries is still pending, the SonntagsZeitung newspaper reported.

Popular Stories

Most Discussed

News

The federal government is working on a new Swiss identity card with a chip

More

New Swiss biometric ID card planned for 2026

This content was published on A biometric Swiss identity card (ID) is expected to be available in Switzerland by the end of 2026. The Federal Office of Police and its federal and cantonal partners are working on a new ID card that features a chip.

Read more: New Swiss biometric ID card planned for 2026
Opportunities for social mobility remain high in Switzerland

More

Swiss continue to enjoy high social mobility, study shows

This content was published on Opportunities for upward social mobility have remained intact in Switzerland since the 1980s. Social mobility is exceptionally high by international comparison, a study shows.

Read more: Swiss continue to enjoy high social mobility, study shows
UBS launches another billion share buyback programme

More

UBS launches buyback scheme for up to $2 billion in shares

This content was published on UBS is starting a share buyback programme for up to $2 billion (CHF1.6 billion) in shares, in line with a plan approved at its annual general meeting (AGM) in April, the Swiss bank said on Monday.

Read more: UBS launches buyback scheme for up to $2 billion in shares

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR